Brussels, 28/06/2005 (Agence Europe) - During their meeting of 24 June, permanent representatives from the Member States again examined the most dispute point in the draft regulation on paediatric trials: the extension time for the certificate of complementary protection for medicines subject to clinical trials will help determine the parameters for their paediatric use. The fifteen older Member States, as well as the Czech Republic, Malta, Cyprus, Lithuania and Estonia, support the...